[{"address1": "19 Vestry Street", "city": "New York", "state": "NY", "zip": "10013", "country": "United States", "phone": "647 865 8622", "website": "https://brightmindsbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatry and neurology indications. Bright Minds Biosciences Inc. has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was founded in 2017 and is headquartered in New York, New York.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Ian  McDonald", "age": 36, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1988, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan E. S. K. Cheung B.Com., C.A., C.P.A.", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 87697, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jan Torleif Pedersen M.Sc., Ph.D.", "age": 59, "title": "Chief Science Officer & Director", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 177806, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Vasilkevich", "title": "COO & Senior Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emer  Leahy M.B.A., Ph.D.", "age": 57, "title": "Consultant", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen D. Collins M.D., Ph.D.", "age": 71, "title": "Chief Medical Officer", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 26.11, "open": 25.44, "dayLow": 25.2576, "dayHigh": 26.08, "regularMarketPreviousClose": 26.11, "regularMarketOpen": 25.44, "regularMarketDayLow": 25.2576, "regularMarketDayHigh": 26.08, "payoutRatio": 0.0, "beta": 0.446, "volume": 13464, "regularMarketVolume": 13464, "averageVolume": 37516, "averageVolume10days": 88770, "averageDailyVolume10Day": 88770, "bid": 25.22, "ask": 26.37, "bidSize": 1, "askSize": 1, "marketCap": 183739248, "fiftyTwoWeekLow": 0.931, "fiftyTwoWeekHigh": 79.02, "fiftyDayAverage": 29.601, "twoHundredDayAverage": 31.62316, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 129430048, "forwardPE": -5.5191493, "profitMargins": 0.0, "floatShares": 2983319, "sharesOutstanding": 7083240, "sharesShort": 86404, "sharesShortPriorMonth": 80327, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.012200001, "heldPercentInsiders": 0.22549, "heldPercentInstitutions": 0.74124, "shortRatio": 3.27, "shortPercentOfFloat": 0.0179, "impliedSharesOutstanding": 7424780, "bookValue": 7.87, "priceToBook": 3.296061, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -3444313, "trailingEps": -0.4, "lastSplitFactor": "1:5", "lastSplitDate": 1689292800, "52WeekChange": 22.736364, "SandP52WeekChange": 0.12632763, "quoteType": "EQUITY", "currentPrice": 25.94, "targetHighPrice": 95.06261, "targetLowPrice": 95.06261, "targetMeanPrice": 95.06261, "targetMedianPrice": 95.06261, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 55679916, "totalCashPerShare": 7.861, "totalDebt": 166596, "quickRatio": 87.643, "currentRatio": 88.273, "debtToEquity": 0.299, "returnOnAssets": -0.10569, "returnOnEquity": -0.11214, "freeCashflow": -2396884, "operatingCashflow": -4142686, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "DRUG", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "REGULAR", "exchange": "NCM", "messageBoardId": "finmb_691048918", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Bright Minds Biosciences Inc.", "corporateActions": [], "regularMarketTime": 1751392674, "twoHundredDayAverageChangePercent": -0.17971508, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-08", "cryptoTradeable": false, "regularMarketChange": -0.17000008, "regularMarketDayRange": "25.2576 - 26.08", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 37516, "fiftyTwoWeekLowChange": 25.009, "fiftyTwoWeekLowChangePercent": 26.862514, "fiftyTwoWeekRange": "0.931 - 79.02", "fiftyTwoWeekHighChange": -53.079994, "fiftyTwoWeekHighChangePercent": -0.6717286, "fiftyTwoWeekChangePercent": 2273.6365, "epsTrailingTwelveMonths": -0.4, "epsCurrentYear": -2.24, "priceEpsCurrentYear": -11.580358, "fiftyDayAverageChange": -3.6609993, "fiftyDayAverageChangePercent": -0.12367823, "twoHundredDayAverageChange": -5.683159, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1616419800000, "regularMarketChangePercent": -0.6510918, "regularMarketPrice": 25.94, "longName": "Bright Minds Biosciences Inc.", "displayName": "Bright Minds Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-07-01"}]